In case you've faced some hurdles solving the clue, Class with makeup tutorials?, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy leisure time, ...

If you are following Replimune Group (REPL) right now, you’re not alone. The company’s recent announcement about completing a Type A meeting with the FDA on its lead drug candidate, RP1, has put it ...

A MURDER probe has been launched after a man died in Aidrie and his brother was rushed to hospital. Mercy crews rushed to the town’s Hamilton Drive in the early hours of yesterday morning. Officers ...

Following a ~39% drop in the previous session, Replimune (NASDAQ:REPL) shares continued to trade lower on Friday as J.P. Morgan downgraded the stock to Underweight from Neutral, citing further ...

We recently published 10 Stocks Losing Big Amid Market Boom. Replimune Group, Inc. (NASDAQ:REPL) is one of the worst performers on Thursday. Replimune extended losses to a second consecutive day on ...

THE boy who disappeared in north Dublin was only identified as missing after a “spot check” by officials from the Department of Social Protection. The Irish Sun can reveal the child’s case was one of ...

AN ‘African tribe’ who set up camp in the woods near a Scottish town claim they were pelted with bricks in their tents. The Kingdom of Kubala moved into the woodland near Jedburgh in the Scottish ...

Though it's been over 27 years since the movie Titanic came out, for one woman, it feels like yesterday. Sarah Boll loves Titanic, telling PEOPLE she's seen the film "over 500 times," having initially ...

Shares of Replimune (NASDAQ:REPL) plunged ~38% in the premarket on Monday after Stat News reported that the FDA’s top regulator of cancer drugs intervened during the review of the company’s lead asset ...

SAN DIEGO, July 30, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Replimune Group, Inc. (NASDAQ: REPL) ...

REPL LEGAL UPDATE: Replimune Group, Inc. Sued after FDA Response Letter -- Investors with Losses are Notified to Contact BFA Law before September 22 Class Action Deadline Leading securities law firm ...